# EDGAR Filing Document

**Accession Number:** 0001665241
**File Stem:** 0001085146-25-005660
**Filing Date:** 2025-8
**Character Count:** 4983
**Document Hash:** f718af5b0f2cd49ad5bc64f64266a37e
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001085146-25-005660.hdr.sgml**: 20250829

**ACCESSION NUMBER**: 0001085146-25-005660

**CONFORMED SUBMISSION TYPE**: N-PX

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20250630

**FILED AS OF DATE**: 20250829

**EFFECTIVENESS DATE**: 20250829

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Schonfeld Strategic Advisors LLC
- **CENTRAL INDEX KEY:** 0001665241

**ORGANIZATION NAME:**
- **EIN:** 475082310
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** N-PX
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 028-17469
- **FILM NUMBER:** 251280707

**BUSINESS ADDRESS:**
- **STREET 1:** 590 MADISON AVENUE
- **STREET 2:** 23RD FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10022
- **BUSINESS PHONE:** 212-832-0900

**MAIL ADDRESS:**
- **STREET 1:** 590 MADISON AVENUE
- **STREET 2:** 23RD FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10022

## FORM N-PX
### ANNUAL REPORT OF PROXY VOTING RECORD

## N-PX: Filer Information

**Filer CIK:** 0001665241

**Date of Report:** 06/30/2025

**Are you a Registered Management Investment Company or an Institutional Manager?:** Institutional Manager

**Is this a LIVE or TEST Filing?:** LIVE

**Is this an electronic copy of an official filing submitted in paper format?:** [ ]

### Submission Contact Information
_Not provided in this filing._

### Notification Information
**Notify via Filing Website only?:** [ ]

## N-PX: Cover Page

**Name of reporting person:** Schonfeld Strategic Advisors LLC

**Address:** 590 MADISON AVENUE, NEW YORK, NY 10022

**Telephone number:** 786-772-5102

**Name of agent for service:** —

**Agent Address:** —, —, — —

**Reporting Period:** Report for the year ended 06/30/2025

**SEC File Number:** 028-17469

**CRD Number (if any):** —

**Other SEC File Number (if any):** —

**LEI (if any):** —

**Report Type (check only one):**

Institutional Manager.

- [x] Institutional Manager Voting Report

- [ ] Institutional Manager Notice Report

- [ ] Institutional Manager Combination Report

Registered Management Investment Company.

- [ ] Fund Voting Report

- [ ] Fund Notice Report

**Do you wish to provide explanatory information pursuant to Special Instruction B.4?:**

- [x] No

- [ ] Yes

**Additional information:** —

## N-PX: Summary - Included Managers

**Number of Included Institutional Managers:** 0

**Included Institutional Managers:** —

## FORM N-PX PROXY VOTING RECORD

| NAME OF ISSUER        | CUSIP     | MEETING DATE   | VOTE DESCRIPTION                                                                                                                                                                                                                   | VOTE CATEGORY                |   SHARES VOTED |   SHARES ON LOAN | HOW VOTED   |   SHARES VOTED FOR OR AGAINST MANAGEMENT | FOR OR AGAINST MANAGEMENT   | OTHER INFO   |
|:---|:---|:---|:---|:---|---:|---:|:---|---:|:---|:---|
| BENITEC BIOPHARMA INC | 08205P209 | 10/17/2024     | Approval of the non-binding advisory vote on the compensation of the Companys named executive officers as disclosed in the attached proxy statement                                                                                | SECTION 14A SAY-ON-PAY VOTES |         260417 |                0 | FOR         |                                   260417 | FOR                         |  |
| CONTEXTLOGIC INC - A  | 21077C305 | 07/10/2025     | To approve, on an advisory basis, our executive compensation for the year ended December 31, 2024, as disclosed herein                                                                                                             | SECTION 14A SAY-ON-PAY VOTES |         984848 |                0 | FOR         |                                   984848 | FOR                         |  |
| MAXLINEAR INC         | 57776J100 | 05/20/2025     | To approve, on an advisory basis, the compensation of our named executive officers for the year ended December 31, 2024, as set forth in the proxy statement                                                                       | SECTION 14A SAY-ON-PAY VOTES |         925000 |                0 | FOR         |                                   925000 | FOR                         |  |
| SKYE BIOSCIENCE INC   | 83086J200 | 10/22/2024     | To approve the Amended and Restated Omnibus Incentive Plan (the "Amended and Restated Plan"), to, among other things, increase the number of shares available for issuance under the Amended and Restated Plan by 1,535,655 shares | SECTION 14A SAY-ON-PAY VOTES |         400000 |                0 | FOR         |                                   400000 | FOR                         |  |

## N-PX: Signature Block

**Reporting Person:** Schonfeld Strategic Advisors LLC

**By (Signature):** Hung Luc

**By (Printed Signature):** Hung Luc

**By (Title):** Chief Compliance Officer

**Date:** 08/29/2025